ArticleAnnals of hematology2024

The clinical efficacy of a daratumumab-based regimen in relapsed/refractory acute leukemia: a single-center experience.

Yi Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.